ERBB2 and breast carcinoma: Human epidermal growth factor receptor 2 (HER2) is a receptor tyrosine-protein kinase, which is widely expressed and can promote tumorigenesis when expression is increased [1]; approximately 15% of breast cancer (BC) cases are HER2-positive, classified by HER2 protein overexpression or HER2 gene amplification [2].